Giant Cell Arteritis

Trials

75 participants · First posted Feb 2, 2007

Recruiting

NCT06500728

Visual Involvement in Giant Cell Arteritis

762 participants · First posted Jul 15, 2024

Not yet recruiting

NCT06244069

Clonal Hematopoiesis in Giant Cell Arteritis

326 participants · First posted Feb 6, 2024

Drugs

View all 4567 →

Biotech

Approved

Tocilizumab(Actemra, RoActemra, Tyenne, Tofidence, Avtozma)

Conditions: Coronavirus Disease 2019 (COVID‑19), Cytokine Release Syndrome caused by CAR-T Cell Therapy +9 more

Rx

biosimilar

Tocilizumab-bavi(TOFIDENCE)

Manufacturer: Organon (regulatory and commercial rights in the US), Bio-Thera Solutions Ltd. (product developer and manufacturer)

Conditions: Rheumatoid Arthritis, Giant Cell Arteritis +4 more

Biotech

Approved

Ambrosia trifida pollen

Organizations

View all 159 →

Giant Compressed Gases Inc

United States

Gamida Cell

Israel

GAMIDA CELL INC.

United States

News

View all 12793 →

last year

Upadacitinib Shows Promise in Treating Giant Cell Arteritis

last year

AbbVie's RINVOQ Receives Positive CHMP Opinion for Giant Cell Arteritis Treatment

last year

Trials

Hydroxychloroquine in Giant Cell Arteritis

Visual Involvement in Giant Cell Arteritis

Clonal Hematopoiesis in Giant Cell Arteritis

Drugs

Tocilizumab(Actemra, RoActemra, Tyenne, Tofidence, Avtozma)

Tocilizumab-bavi(TOFIDENCE)

Ambrosia trifida pollen

Organizations

Giant Compressed Gases Inc

Gamida Cell

GAMIDA CELL INC.

News

Upadacitinib Shows Promise in Treating Giant Cell Arteritis

AbbVie's RINVOQ Receives Positive CHMP Opinion for Giant Cell Arteritis Treatment

CHMP Backs AbbVie's Rinvoq for Giant Cell Arteritis Treatment in Adults